Skip to content
If you can read this, either the style sheet didn't load or you have an older browser that doesn't support style sheets. Try clearing your browser cache and refreshing the page.

(Medical Xpress)   And then there was one... maybe, not likely but maybe... hope springs eternal   ( divider line
    More: Interesting, Immune system, Common cold, Severe acute respiratory syndrome, prior coronavirus infections, SARS-CoV-1 strain, universal coronavirus vaccines, common cold coronavirus, Influenza  
•       •       •

1418 clicks; posted to STEM » on 17 Oct 2021 at 8:53 PM (30 weeks ago)   |   Favorite    |   share:  Share on Twitter share via Email Share on Facebook

Voting Results (Smartest)
View Voting Results: Smartest and Funniest

2021-10-17 6:41:39 PM  
4 votes:
I'm just thrilled that scientists and researchers are all over this, before The Next Big Thing.
2021-10-17 11:50:34 PM  
4 votes:

lindalouwho: I'm just thrilled that scientists and researchers are all over this, before The Next Big Thing.

they WERE all over this before TFG destroyed our pandemic readiness infrastructure to stiggit to the libs.  We had people in China cooperating and monitoring potential new pandemics ffs. remember SARS got shut down pretty fast.

Scientists tend to know their fields.
2021-10-17 11:09:07 PM  
3 votes:
Rhinovirus vaccine is aiming for a 2024 release.  Between the two, it will once again be safe to touch the break room coffee pot and pour a cup of something that tastes like anything but coffee.
2021-10-18 12:16:41 AM  
1 vote:
The cross-protection works the other way as well, as it should. Exposure to common-cold coronaviruses confers resistance to COVID-19.
Displayed 4 of 4 comments

View Voting Results: Smartest and Funniest

This thread is closed to new comments.

Continue Farking

On Twitter

  1. Links are submitted by members of the Fark community.

  2. When community members submit a link, they also write a custom headline for the story.

  3. Other Farkers comment on the links. This is the number of comments. Click here to read them.

  4. Click here to submit a link.